NLM Logo

Alemtuzumab MeSH Descriptor Data 2022


MeSH Heading
Alemtuzumab
Tree Number(s)
D12.776.124.486.485.114.224.060.313
D12.776.124.790.651.114.224.060.375
D12.776.377.715.548.114.224.200.375
Unique ID
D000074323
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000074323
Scope Note
An anti-CD52 ANTIGEN monoclonal antibody used for the treatment of certain types of CD52-positive lymphomas (e.g., CHRONIC LYMPHOCYTIC LEUKEMIA; CUTANEOUS T-CELL LYMPHOMA; and T-CELL LYMPHOMA). Its mode of actions include ANTIBODY-DEPENDENT CELL CYTOTOXICITY.
Entry Term(s)
Campath
Campath 1G
Campath 1H
Campath 1M
Campath-1-G
Campath-1G
Campath-1H
Campath-1M
Lemtrada
MabCambath
Monoclonal Antibody Campath-1H
Pharm Action
Antineoplastic Agents, Immunological
Registry Number
3A189DH42V
See Also
CD52 Antigen
Public MeSH Note
2018; ALEMTUZUMAB was indexed under ANTIBODIES, MONOCLONAL, 1995-2011 and under ANTIBODIES, MONOCLONAL, HUMANIZED, 2012-2017
History Note
2018 (1995)
Date Established
2018/01/01
Date of Entry
2017/07/11
Revision Date
2017/04/10
Alemtuzumab Preferred
Campath 1H Narrower
Campath 1M Narrower
MabCambath Narrower
Lemtrada Narrower
Campath 1G Narrower
Campath Narrower
page delivered in 0.187s